New York State Common Retirement Fund
CLDX icon

New York State Common Retirement Fund’s Celldex Therapeutics CLDX Stock Holding History

New York State Common Retirement Fund’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
28,437
+6,200
+28% +$200K ﹤0.01% 1731
2026
Q1 		$705K Hold
22,237
– – ﹤0.01% 1790
2025
Q4 		$604K Hold
22,237
– – ﹤0.01% 1893
2025
Q3 		$575K Hold
22,237
– – ﹤0.01% 1894
2025
Q2 		$453K Hold
22,237
– – ﹤0.01% 1934
2025
Q1 		$404K Hold
22,237
– – ﹤0.01% 1957
2024
Q4 		$562K Hold
22,237
– – ﹤0.01% 1905
2024
Q3 		$756K Sell
22,237
-7,500
-25% -$286K ﹤0.01% 1771
2024
Q2 		$1.1M Buy
29,737
+2,947
+11% +$111K ﹤0.01% 1718
2024
Q1 		$1.12M Buy
26,790
+4,674
+21% +$192K ﹤0.01% 1721
2023
Q4 		$877K Sell
22,116
-1,664
-7% -$48.9K ﹤0.01% 1847
2023
Q3 		$654K Buy
23,780
+821
+4% +$25.7K ﹤0.01% 1948
2023
Q2 		$779K Sell
22,959
-4,586
-17% -$155K ﹤0.01% 1897
2023
Q1 		$991K Sell
27,545
-5,134
-16% -$222K ﹤0.01% 1873
2022
Q4 		$1.46M Sell
32,679
-40
-0.1% -$1.43K ﹤0.01% 1798
2022
Q3 		$920K Buy
32,719
+97
+0.3% +$2.97K ﹤0.01% 2023
2022
Q2 		$879K Sell
32,622
-83
-0.3% -$2.41K ﹤0.01% 2085
2022
Q1 		$1.11M Buy
32,705
+24
+0.1% +$767 ﹤0.01% 2057
2021
Q4 		$1.26M Buy
32,681
+2,165
+7% +$94.3K ﹤0.01% 2017
2021
Q3 		$1.65M Sell
30,516
-3,084
-9% -$145K ﹤0.01% 1860
2021
Q2 		$1.12M Buy
+33,600
New +$922K ﹤0.01% 2168
2018
Q2 		– Sell
-7,553
Closed -$264K – 3179
2018
Q1 		$264K Hold
7,553
– – ﹤0.01% 2625
2017
Q4 		$322K Buy
7,553
+1,186
+19% +$50.8K ﹤0.01% 2550
2017
Q3 		$273K Hold
6,367
– – ﹤0.01% 2631
2017
Q2 		$236K Sell
6,367
-1,433
-18% -$63.4K ﹤0.01% 2764
2017
Q1 		$422K Hold
7,800
– – ﹤0.01% 2462
2016
Q4 		$414K Hold
7,800
– – ﹤0.01% 2448
2016
Q3 		$473K Hold
7,800
– – ﹤0.01% 2336
2016
Q2 		$514K Sell
7,800
-5,056
-39% -$321K ﹤0.01% 2270
2016
Q1 		$729K Hold
12,856
– – ﹤0.01% 2096
2015
Q4 		$3.02M Sell
12,856
-1,478
-10% -$322K ﹤0.01% 1439
2015
Q3 		$2.27M Buy
14,334
+717
+5% +$203K ﹤0.01% 1547
2015
Q2 		$5.15M Buy
13,617
+1,797
+15% +$714K 0.01% 1335
2015
Q1 		$4.94M Buy
11,820
+1,620
+16% +$580K 0.01% 1217
2014
Q4 		$2.79M Buy
10,200
+1,613
+19% +$401K ﹤0.01% 1480
2014
Q3 		$1.67M Hold
8,587
– – ﹤0.01% 1697
2014
Q2 		$2.1M Sell
8,587
-22,990
-73% -$5.19M ﹤0.01% 1645
2014
Q1 		$8.37M Buy
31,577
+3,114
+11% +$1.19M 0.01% 1002
2013
Q4 		$10.3M Buy
+28,463
New +$11M 0.02% 899

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund's CLDX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Celldex Therapeutics (CLDX) stake by 28% in Q2 2026, buying an estimated $200K and bringing the position to 28,437 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

New York State Common Retirement Fund first reported a position in CLDX in Q4 2013 and has held it in 39 quarters since. The position peaked at $10.3M in Q4 2013. 253 funds tracked by Wall St. Rank hold CLDX as of Q2 2026.

  • New York State Common Retirement Fund held 28,437 shares of Celldex Therapeutics worth $1.06M as of Q2 2026.
  • New York State Common Retirement Fund bought 6,200 Celldex Therapeutics shares in Q2 2026, an estimated $200K.
  • Celldex Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1731 holding.
  • New York State Common Retirement Fund first reported a position in Celldex Therapeutics in Q4 2013 and has held it in 39 quarters since.
  • New York State Common Retirement Fund's Celldex Therapeutics position peaked at $10.3M in Q4 2013.
  • 253 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.